Article info

Download PDFPDF

Original research
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses

Authors

  • Helena Florez Metabolic Bone Diseases Unit, Department of Rheumatology, IDIBAPS, CIBERehd, University of Barcelona, Hospital Clínic de Barcelona, Spain Department of Rheumatology, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Jose Hernández-Rodríguez Department of Autoimmune Diseases, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Josep Lluis Carrasco Biostatistics, Department of Basic Clinical Practice, University of Barcelona, Spain PubMed articlesGoogle scholar articles
  • Sergio Prieto-González Department of Autoimmune Diseases, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Africa Muxi Department of Nuclear Medicine, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Xavier Filella Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Silvia Ruiz-Gaspà Metabolic Bone Diseases Unit, Department of Rheumatology, IDIBAPS, CIBERehd, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • José A Gómez-Puerta Department of Rheumatology, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Maria Cid Department of Autoimmune Diseases, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Gerard Espinosa Department of Autoimmune Diseases, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ana Monegal Metabolic Bone Diseases Unit, Department of Rheumatology, IDIBAPS, CIBERehd, University of Barcelona, Hospital Clínic de Barcelona, Spain Department of Rheumatology, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Núria Guañabens Metabolic Bone Diseases Unit, Department of Rheumatology, IDIBAPS, CIBERehd, University of Barcelona, Hospital Clínic de Barcelona, Spain Department of Rheumatology, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  • Pilar Peris Metabolic Bone Diseases Unit, Department of Rheumatology, IDIBAPS, CIBERehd, University of Barcelona, Hospital Clínic de Barcelona, Spain Department of Rheumatology, University of Barcelona, Hospital Clínic de Barcelona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Helena Florez; hflorez{at}clinic.cat
View Full Text

Citation

Florez H, Hernández-Rodríguez J, Carrasco JL, et al
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses

Publication history

  • Received June 7, 2020
  • Revision received July 17, 2020
  • Accepted August 10, 2020
  • First published September 10, 2020.
Online issue publication 
September 10, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.